Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.398
+0.017 (4.57%)
At close: Nov 4, 2024, 4:00 PM
0.386
-0.012 (-2.94%)
After-hours: Nov 4, 2024, 7:30 PM EST
APTO's stock price has decreased by -86.7% in the past year and price targets may not have had time to catch up.
Aptose Biosciences Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$9.00
Upside
+2,162.44%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,659.68% | Jun 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +1,408.30% | May 16, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $5 | Buy | Maintains | $5 | +1,156.91% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +5,681.80% | Mar 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +1,156.91% | Feb 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $18 | Buy | Maintains | $23 → $18 | +4,424.89% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $38 | Buy | Reiterates | $38 | +9,452.54% | Sep 7, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $37 → $12 | Buy | Maintains | $37 → $12 | +2,916.59% | Aug 11, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $23 | Buy | Maintains | $40 → $23 | +5,681.80% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $23 | Strong Buy | Maintains | $12 → $23 | +5,681.80% | Aug 11, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $15 | Buy | Maintains | $50 → $15 | +3,670.74% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $23 | Strong Buy | Maintains | $12 → $23 | +5,681.80% | Jun 12, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $6 → $38 | Buy | Maintains | $6 → $38 | +9,452.54% | Jun 12, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $50 | Buy | Maintains | $9 → $50 | +12,469.13% | Jun 12, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $37 | Buy | Maintains | $45 → $37 | +9,201.16% | Jun 7, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $40 | Buy | Maintains | $75 → $40 | +9,955.30% | Jun 7, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.